Inter-individual variability in equine antibody responses to African snake venoms follows heavy-tailed distributions with implications for antivenom production

  Inter-individual variability in equine antibody responses to African snake venoms follows heavy-tailed distributions with implications for antivenom production Abstract Variability in the antibody response of horses used for snake antivenom manufacture is well recognized, yet its statistical structure and implications for industrial productivity remain poorly characterized. In this study, we quantified antivenom antibody titers by ELISA in a cohort of 14 horses immunized with venoms from the clinically most important snakes in sub-Saharan Africa. To integrate antibody levels with plasma availability, we calculated the Cumulative Plasma Productivity (CPP) by converting individual plasma volumes into titer-corrected equivalents and sequentially pooling these volumes according to their corrected contribution. Distributional analysis revealed right-skewed, heavy-tailed patterns better approximated by a log-normal model than by a strict Pareto (power-law) form, with approximately 20–3...

Paralysis Efficiency (PD50) Scales Linearly with Lethality (LD50) in Spider Venoms

 


Paralysis Efficiency (PD50) Scales Linearly with Lethality (LD50) in Spider Venoms

Abstract

Historically, venom potencies have been assessed using measures of lethality, such as the median lethal dose (LD50). However, venoms may be selected primarily for their ability to rapidly incapacitate rather than cause mortality, meaning LD50 may not capture the efficacy of venoms in an ecological and evolutionary context. To capture this context, recent studies have adapted measures that assess venoms’ ability to rapidly incapacitate, such as the median paralysis dose (PD50). However, while PD50 values are expected to provide a more proximate assessment of ecological variation in venom potency, it is unknown whether historically available LD50 values are still useful proxies of ecologically relevant potency or whether they capture independent axes of venom variation. Here, we test the relationship between LD50 and PD50 in spider venoms by experimentally estimating LD50 and PD50 for 12 species and collating additional potency data for 46 species retrieved from the literature, producing a dataset of 55 species spanning 26 families when combined. We observed a linear isometric relationship between LD50 and PD50, showing these potency measures are both strongly correlated, with an increase in paralysis efficiency associated with a similar increase in lethality. Our results suggest that due to the correlation between functional aspects of venom potency, paralysis and lethality, historically available LD50 values may be used to compare general venom potencies in spiders, provided that they are based on the same prey model.
Lyons, K., Leonard, D., McSharry, L., Martindale, M., Collier, B. L., Vitkauskaite, A., Dunbar, J. P., Dugon, M. M., & Healy, K. (2026). Paralysis Efficiency (PD50) Scales Linearly with Lethality (LD50) in Spider Venoms. Toxicon: X, 100256. https://doi.org/10.1016/j.toxcx.2026.100256